SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-21-144968
Filing Date
2021-04-30
Accepted
2021-04-30 16:04:07
Documents
7

Document Format Files

Seq Description Document Type Size
1 DEFA14A d107927ddefa14a.htm DEFA14A 29450
2 GRAPHIC g1079271b.jpg GRAPHIC 1440
3 GRAPHIC g1079271c.jpg GRAPHIC 1446
4 GRAPHIC g107927g92a01.jpg GRAPHIC 5334
5 GRAPHIC g107927g92d04.jpg GRAPHIC 1805
6 GRAPHIC g107927g92e05.jpg GRAPHIC 1633
7 GRAPHIC g107927g92f06.jpg GRAPHIC 2251
  Complete submission text file 0001193125-21-144968.txt   50542
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33277 | Film No.: 21877754
SIC: 2834 Pharmaceutical Preparations